Low dose anticoagulation not without risks “real-world” trial shows  

Low dose anticoagulation is associated with higher bleeding and thrombotic events in frail patients with non-valvular AF compared to those receiving full dose anticoagulation, according to findings from the first real world Australian data to report DOAC safety in high-risk patients. Investigators from the Northern Hospital in Victoria who conducted the retrospective analysis say that ...

Already a member?

Login to keep reading.

© 2022 the limbic